ArticlePloS one2017

A BCR-ABL1 cutoff of 1.5% at 3 months, determined by the GeneXpert system, predicts an optimal response in patients with chronic myeloid leukemia.

Valentín García-Gutiérrez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.